Compare IDXX & MSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | MSTR |
|---|---|---|
| Founded | 1983 | 1989 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 57.4B |
| IPO Year | N/A | N/A |
| Metric | IDXX | MSTR |
|---|---|---|
| Price | $636.52 | $125.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $715.00 | $369.08 |
| AVG Volume (30 Days) | 486.0K | ★ 19.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.81 | $2.70 |
| Revenue Next Year | $8.62 | N/A |
| P/E Ratio | $48.54 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $356.25 | $105.00 |
| 52 Week High | $769.98 | $457.22 |
| Indicator | IDXX | MSTR |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 40.91 |
| Support Level | $606.04 | $120.64 |
| Resistance Level | $651.57 | $135.25 |
| Average True Range (ATR) | 18.78 | 11.61 |
| MACD | -1.74 | -0.04 |
| Stochastic Oscillator | 37.23 | 40.88 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software.